<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Res Pharm Pract</journal-id><journal-id journal-id-type="iso-abbrev">J Res Pharm Pract</journal-id><journal-id journal-id-type="publisher-id">JRPP</journal-id><journal-title-group><journal-title>Journal of Research in Pharmacy Practice</journal-title></journal-title-group><issn pub-type="ppub">2319-9644</issn><issn pub-type="epub">2279-042X</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27843960</article-id><article-id pub-id-type="pmc">5084481</article-id><article-id pub-id-type="publisher-id">JRPP-5-248</article-id><article-id pub-id-type="doi">10.4103/2279-042X.192462</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Addition of cranberry to proton pump inhibitor-based triple therapy for <italic>Helicobacter pylori</italic> eradication</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Seyyedmajidi</surname><given-names>Mohammadreza</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ahmadi</surname><given-names>Anahita</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hajiebrahimi</surname><given-names>Shahin</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Seyedmajidi</surname><given-names>Seyedali</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rajabikashani</surname><given-names>Majid</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Firoozabadi</surname><given-names>Mona</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Vafaeimanesh</surname><given-names>Jamshid</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1"/></contrib></contrib-group><aff id="aff1"><label>1</label>Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Golestan Province, Iran</aff><aff id="aff2"><label>2</label>Qom Gastroenterology and Hepatology Research Center, Qom University of Medical Sciences, Qom, Iran</aff><aff id="aff3"><label>3</label>Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran</aff><author-notes><corresp id="cor1"><bold>Corresponding author:</bold> Dr. Jamshid Vafaeimanesh, E-mail: <email xlink:href="j.vafaeemanesh@muq.ac.ir">j.vafaeemanesh@muq.ac.ir</email></corresp></author-notes><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2016</year></pub-date><volume>5</volume><issue>4</issue><fpage>248</fpage><lpage>251</lpage><history><date date-type="received"><month>5</month><year>2016</year></date><date date-type="accepted"><month>6</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2016 Journal of Research in Pharmacy Practice</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Objective:</title><p>Proton pump inhibitor-based triple therapy with two antibiotics for <italic>Helicobacter pylori</italic> eradication is widely accepted, but this combination fails in a considerable number of cases. Some studies have shown that cranberry inhibits the adhesion of a wide range of microbial pathogens, including <italic>H. pylori</italic>. The aim of this study was to assess the effect of cranberry on <italic>H. pylori</italic> eradication with a standard therapy including lansoprazole, clarithromycin, and amoxicillin (LCA) in patients with peptic ulcer disease (PUD).</p></sec><sec id="st2"><title>Methods:</title><p>In this study, <italic>H. pylori</italic>-positive patients with PUD were randomized into two groups: Group A: A 14-day LCA triple therapy with 30 mg lansoprazole bid, 1000 mg amoxicillin bid, and 500 mg clarithromycin bid; Group B: A 14-day 500 mg cranberry capsules bid plus LCA triple therapy. A <sup>13</sup>C-urea breath test was performed for eradication assessment 6 weeks after the completion of the treatment.</p></sec><sec id="st3"><title>Findings:</title><p>Two hundred patients (53.5% males, between 23 and 77 years, mean age &#x000b1; standard deviation: 50.29 &#x000b1; 17.79 years) continued treatment protocols and underwent <sup>13</sup>C-urea breath testing. <italic>H. pylori</italic> eradication was achieved in 74% in Group A (LCA without cranberry) and 89% in Group B (LCA with cranberry) (<italic>P</italic> = 0.042).</p></sec><sec id="st4"><title>Conclusion:</title><p>The addition of cranberry to LCA triple therapy for <italic>H. pylori</italic> has a higher rate of eradication than the standard regimen alone (up to 89% and significant).</p></sec></abstract><kwd-group><title>Keywords</title><kwd>Cranberry</kwd><kwd>eradication therapy</kwd><kwd><italic>Helicobacter pylori</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p><italic>Helicobacter pylori</italic> is a Gram-negative, spiral-shaped microorganism that infects approximately half of the world population.[<xref rid="ref1" ref-type="bibr">1</xref>] Gastric infection by <italic>H. pylori</italic> is considered to be the most relevant cause of chronic gastritis, peptic ulcer disease (PUD), mucosa-associated lymphoid tissue lymphoma, and gastric cancer.[<xref rid="ref2" ref-type="bibr">2</xref>] Selection of the best drug regimens for eradication of <italic>H. pylori</italic> infection is already challenging. Antibiotic resistance due to frequent and uncontrolled use and the high prevalence of antibiotic side effects are the most common causes for treatment failure. To increase the eradication rates, as defined in the Maastricht IV report,[<xref rid="ref3" ref-type="bibr">3</xref>] several clinical trials have been initiated involving extended treatment duration, the use of new antibiotics, or the addition of probiotics or other drugs to therapy.</p><p>There is a growing public interest for cranberry, blueberry, and relatively new gooseberry as a functional food because of the potential health benefits linked to phytochemical compounds responsible for secondary plant metabolites (flavonols, flavan-3-ols, proanthocyanidins, and phenolic acid derivatives).[<xref rid="ref4" ref-type="bibr">4</xref>] Cranberry (<italic>Vaccinium macrocarpon</italic> Ait.) is a member of the <italic>Ericaceae</italic> (the heath family). This fruit was collected from the wild by American Indians and used for a variety of purposes including as a preservative of fish and meat and medicinally as a poultice for dressing wounds.[<xref rid="ref5" ref-type="bibr">5</xref>] Cranberry, in particular,[<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref>] helps prevent urinary tract infections,[<xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref>] and has some anticancer properties.[<xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref>] Some studies have shown that cranberry juice constituents inhibit the adhesion of a wide range of microbial pathogens, including <italic>H. pylori</italic>, <italic>E. coli</italic>, oral bacteria, and influenza virus.[<xref rid="ref13" ref-type="bibr">13</xref>] Cranberry proanthocyanidins can be used as an adjunct to increase intestinal secretory immunoglobulin A (sIgA) levels in mice receiving enteral nutrition.[<xref rid="ref14" ref-type="bibr">14</xref>] The aim of this study was to compare the effect of cranberry on <italic>H. pylori</italic> eradication with a triple therapy including lansoprazole, clarithromycin, and amoxicillin (LCA) in patients with PUD.</p></sec><sec sec-type="methods" id="sec1-2"><title>METHODS</title><p>A prospective, open-label, randomized clinical trial study was conducted on 200 consecutive <italic>H. pylori</italic>-infected patients with PUD between June 2014 and September 2015. All of them were referred to our academic hospital in Gorgan (North of Iran). Exclusion criteria were previous <italic>H. pylori</italic> eradication, consumption of aspirin, nonsteroid anti-inflammatory drugs, proton pump inhibitors, warfarin, bismuth preparations, or antibiotics during the last 8 weeks. Patients with renal and hepatic impairment were not enrolled. Gastroscopy was done using a videoscope (Olympus GIF-XQ260, Japan), and two specimens were obtained from the antrum. <italic>H. pylori</italic> infection was diagnosed by histopathological examination. This research was approved by the Ethical Committee of Golestan University of Medical Sciences. Informed consent was obtained from all patients.</p><p>Initially, 250 patients were evaluated for inclusion, and finally, 200 patients were studied [<xref ref-type="fig" rid="F1">Figure 1</xref>]. Patients were enrolled into one of the following groups: Group A (control group, <italic>n</italic> = 100): The patients were given a 14-day standard LCA triple therapy for <italic>H. pylori</italic> infection eradication with 30 mg lansoprazole (Lanzo Doctor Abidi Company) bid, 1000 mg amoxicillin bid, and 500 mg clarithromycin bid; Group B (case group, <italic>n</italic> = 100): In this group, the patients were given a 14-day 500 mg cranberry capsules (Liver Company, Canada) bid plus LCA triple therapy. Patients were asked to return at the end of the treatment to assess the compliance with therapy that was defined as consumption of &#x0003e;80% of the prescribed drugs. A <sup>13</sup>C-urea breath test was performed for <italic>H. pylori</italic> eradication assessment 6 weeks after the completion of the treatment.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Flow diagram of the study</p></caption><graphic xlink:href="JRPP-5-248-g001"/></fig><p>Statistical analysis was performed using Chi-square test, Fisher's exact test, and one-way analysis of variance test. <italic>P</italic> &#x02264; 0.05 was considered statistically significant. All the data were analyzed using SPSS 18 for Windows (SPSS Inc., Chicago, IL, USA) and the values were expressed as the mean &#x000b1; standard deviation (SD) for continuous variables and percentages for categorical variables.</p></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>Two hundred patients (53.5% males, between 23 and 77 years, mean age &#x000b1; SD: 50.29 &#x000b1; 17.79 years) continued treatment protocols and underwent <sup>13</sup>C-urea breath testing. There were no statistically significant differences between the two groups regarding age, gender, and body mass index. <italic>H. pylori</italic> eradication was achieved in 74% patients in Group A (LCA without cranberry) and 89% patients in Group B (LCA with cranberry). The difference was statistically significant (<italic>P</italic> = 0.042) [<xref ref-type="table" rid="T1">Table 1</xref>]. As shown in this table, there was no significant difference between the study groups in the rate of <italic>H. pylori</italic> eradication on the basis of sex (<italic>P</italic> = 0.912 for standard LCA therapy and <italic>P</italic> = 0.785 for LCA with cranberry).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><italic>Helicobacter pylori</italic> eradication rates of study subjects in two groups</p></caption><graphic xlink:href="JRPP-5-248-g002"/></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p><italic>In vitro</italic> studies have shown that cranberry juice inhibits the adhesion of microbial pathogens, including <italic>H. pylori</italic>, uropathogenic <italic>E. coli</italic>, oral bacteria, and influenza virus.[<xref rid="ref13" ref-type="bibr">13</xref>] Cranberry proanthocyanidins can be used as an adjunct to increase intestinal sIgA levels in mice receiving enteral nutrition.[<xref rid="ref14" ref-type="bibr">14</xref>] A clinical investigation found that consuming a cranberry for 10 weeks resulted in a 5-fold increase in proliferation of T cells, a 30% increase in NK cell proliferation, and a 20% reduction in interleukin 17 secretion, as well as a significant reduction in cold and flu symptoms compared to placebo.[<xref rid="ref15" ref-type="bibr">15</xref>] Nantz <italic>et al</italic>. reported that consumption of the cranberry modified the ex vivo proliferation of &#x003b3;&#x003b4;-T cells. As these cells are located in the epithelium and serve as the first line of defense, improving their function may be related to reducing the number of symptoms associated with infection.[<xref rid="ref16" ref-type="bibr">16</xref>]</p><p>Some studies showed that cranberry inhibited the adhesion of two-thirds of tested clinical isolates of <italic>H. pylori</italic> including bacteria expressing sialic acid-specific adhesion, and researchers hypothesized that cranberry juice might have the ability to eradicate <italic>H. pylori</italic>
<italic>in vivo</italic>.[<xref rid="ref17" ref-type="bibr">17</xref><xref rid="ref18" ref-type="bibr">18</xref>] However, cranberry juice in a mice model of <italic>H. pylori</italic> infection caused a significant clearance of the <italic>H. pylori</italic> mass; however, it had no effect on eradicating the pathogen from the gastric lumen.[<xref rid="ref19" ref-type="bibr">19</xref>] In one study, cranberry juice alone accounted for a 15% of the <italic>H. pylori</italic> eradication, compared to 5% for placebo. Although this effect was significant, the rate of eradication was still considerably lower than that of conventional therapy.[<xref rid="ref20" ref-type="bibr">20</xref>]</p><p>Here, we reported that adding cranberry capsules to the standard regimen for treating <italic>H. pylori</italic> has a higher rate of eradication than the standard regimen alone (up to 89% and significant). Assessment of cranberry extract and probiotics[<xref rid="ref21" ref-type="bibr">21</xref>] showed that the combination of the cranberry with a probiotic is the most effective treatment in <italic>H. pylori</italic> in children. Zhang <italic>et al</italic>. used cranberry juice for treatment of <italic>H. pylori</italic> in adults for 90 days and reported that regular consumption of cranberry juice could suppress <italic>H. pylori</italic> infection in endemically afflicted populations.[<xref rid="ref20" ref-type="bibr">20</xref>] In another study, adding cranberry juice to the standard treatment improves the rate of <italic>H. pylori</italic> eradication in females;[<xref rid="ref13" ref-type="bibr">13</xref>] however, in our study, there was no significant difference between two groups in the rate of <italic>H. pylori</italic> eradication on the basis of sex.</p><p>This study indicated a potential beneficial effect of cranberry in increasing the rate of H. Pylori eradication; however, the results shown here are only preliminary, and further studies are necessary. Two-week cranberry consumption is an inexpensive and available supplement; however, cranberry is a native North America plant, and in Iran, the only form available is capsules. In most of the studies, juice and dried fruit of cranberry were used and maybe the capsule forms are not as effective as the other forms. Further assessment for defining the best form of cranberry for different clinical situations is necessary.</p></sec><sec id="sec1-5"><title>AUTHORS' CONTRIBUTION</title><p>Mohammadreza Seyyedmajidi: Reviewing of literature, Study design, Data collection, analysis and manuscript preparation Reviewing of literature and manuscript editing. Anahita Ahmadi: Reviewing of literature, Data collection, Shahin Hajiebrahimi: Reviewing of literature, Data collection, Seyedali Seyedmajidi: Reviewing of literature, Data collection, Majid Rajabikashani: Reviewing of literature, Data collection, Mona Firoozabadi: Reviewing of literature, Data collection, Jamshid Vafaeimanesh: Reviewing of literature, Study design, and manuscript editing.</p><sec id="sec2-1"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-2"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>This study was supported by the Golestan Research Center of Gastroenterology and Hepatology. We wish to thank all the researchers who took part in this research project and Doctor Abidi Company members for drugs provision.</p></ack><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correa</surname><given-names>P</given-names></name><name><surname>Houghton</surname><given-names>J</given-names></name></person-group><article-title>Carcinogenesis of <italic>Helicobacter pylori</italic></article-title><source>Gastroenterology</source><year>2007</year><volume>133</volume><fpage>659</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">17681184</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seyedmajidi</surname><given-names>S</given-names></name><name><surname>Mirsattari</surname><given-names>D</given-names></name><name><surname>Zojaji</surname><given-names>H</given-names></name><name><surname>Zanganeh</surname><given-names>E</given-names></name><name><surname>Seyyedmajidi</surname><given-names>M</given-names></name><name><surname>Almasi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Penbactam for <italic>Helicobacter pylori</italic> eradication: A randomised comparison of quadruple and triple treatment schedules in an Iranian population</article-title><source>Arab J Gastroenterol</source><year>2013</year><volume>14</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">23622801</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malfertheiner</surname><given-names>P</given-names></name><name><surname>Megraud</surname><given-names>F</given-names></name><name><surname>O'Morain</surname><given-names>CA</given-names></name><name><surname>Atherton</surname><given-names>J</given-names></name><name><surname>Axon</surname><given-names>AT</given-names></name><name><surname>Bazzoli</surname><given-names>F</given-names></name><etal/></person-group><article-title>Management of <italic>Helicobacter pylori</italic> infection &#x02013; the Maastricht IV/Florence Consensus Report</article-title><source>Gut</source><year>2012</year><volume>61</volume><fpage>646</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">22491499</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namiesnik</surname><given-names>J</given-names></name><name><surname>Vearasilp</surname><given-names>K</given-names></name><name><surname>Nemirovski</surname><given-names>A</given-names></name><name><surname>Leontowicz</surname><given-names>H</given-names></name><name><surname>Leontowicz</surname><given-names>M</given-names></name><name><surname>Pasko</surname><given-names>P</given-names></name><etal/></person-group><article-title><italic>In vitro</italic> studies on the relationship between the antioxidant activities of some berry extracts and their binding properties to serum albumin</article-title><source>Appl Biochem Biotechnol</source><year>2014</year><volume>172</volume><fpage>2849</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">24449373</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seeram</surname><given-names>NP</given-names></name></person-group><article-title>Berry fruits: Compositional elements, biochemical activities, and the impact of their intake on human health, performance, and disease</article-title><source>J Agric Food Chem</source><year>2008</year><volume>56</volume><fpage>627</fpage><lpage>9</lpage></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polashock</surname><given-names>J</given-names></name><name><surname>Zelzion</surname><given-names>E</given-names></name><name><surname>Fajardo</surname><given-names>D</given-names></name><name><surname>Zalapa</surname><given-names>J</given-names></name><name><surname>Georgi</surname><given-names>L</given-names></name><name><surname>Bhattacharya</surname><given-names>D</given-names></name><etal/></person-group><article-title>The American cranberry:First insights into the whole genome of a species adapted to bog habitat</article-title><source>BMC Plant Biol</source><year>2014</year><volume>14</volume><fpage>165</fpage><pub-id pub-id-type="pmid">24927653</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Murphy</surname><given-names>BT</given-names></name><name><surname>Hammond</surname><given-names>GB</given-names></name><name><surname>Vinson</surname><given-names>JA</given-names></name><name><surname>Neto</surname><given-names>CC</given-names></name></person-group><article-title>Antioxidant activities and antitumor screening of extracts from cranberry fruit (Vaccinium macrocarpon)</article-title><source>J Agric Food Chem</source><year>2002</year><volume>50</volume><fpage>5844</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12358448</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>AB</given-names></name><name><surname>Vorsa</surname><given-names>N</given-names></name><name><surname>Der Marderosian</surname><given-names>A</given-names></name><name><surname>Foo</surname><given-names>LY</given-names></name></person-group><article-title>Inhibition of the adherence of P-fimbriated <italic>Escherichia coli</italic> to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries</article-title><source>N Engl J Med</source><year>1998</year><volume>339</volume><fpage>1085</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9767006</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>AB</given-names></name></person-group><article-title>Cranberry proanthocyanidins and the maintenance of urinary tract health</article-title><source>Crit Rev Food Sci Nutr</source><year>2002</year><volume>42</volume><issue>3 Suppl</issue><fpage>273</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12058985</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vorsa</surname><given-names>N</given-names></name><name><surname>Polashock</surname><given-names>J</given-names></name><name><surname>Howell</surname><given-names>A</given-names></name><name><surname>Cunningham</surname><given-names>D</given-names></name><name><surname>Roderick</surname><given-names>R</given-names></name></person-group><article-title>Evaluation of fruit chemistry in cranberry germplasm: Potential for breeding varieties with enhanced health constituents</article-title><source>Acta Hortic</source><year>2002</year><volume>574</volume><fpage>215</fpage><lpage>20</lpage></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neto</surname><given-names>CC</given-names></name></person-group><article-title>Cranberries: Ripe for more cancer research?</article-title><source>J Sci Food Agric</source><year>2011</year><volume>91</volume><fpage>2303</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21910124</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>AP</given-names></name><name><surname>Singh</surname><given-names>RK</given-names></name><name><surname>Kim</surname><given-names>KK</given-names></name><name><surname>Satyan</surname><given-names>KS</given-names></name><name><surname>Nussbaum</surname><given-names>R</given-names></name><name><surname>Torres</surname><given-names>M</given-names></name><etal/></person-group><article-title>Cranberry proanthocyanidins are cytotoxic to human cancer cells and sensitize platinum-resistant ovarian cancer cells to paraplatin</article-title><source>Phytother Res</source><year>2009</year><volume>23</volume><fpage>1066</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">19172579</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shmuely</surname><given-names>H</given-names></name><name><surname>Yahav</surname><given-names>J</given-names></name><name><surname>Samra</surname><given-names>Z</given-names></name><name><surname>Chodick</surname><given-names>G</given-names></name><name><surname>Koren</surname><given-names>R</given-names></name><name><surname>Niv</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Effect of cranberry juice on eradication of <italic>Helicobacter pylori</italic> in patients treated with antibiotics and a proton pump inhibitor</article-title><source>Mol Nutr Food Res</source><year>2007</year><volume>51</volume><fpage>746</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">17487928</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierre</surname><given-names>JF</given-names></name><name><surname>Heneghan</surname><given-names>AF</given-names></name><name><surname>Feliciano</surname><given-names>RP</given-names></name><name><surname>Shanmuganayagam</surname><given-names>D</given-names></name><name><surname>Krueger</surname><given-names>CG</given-names></name><name><surname>Reed</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Cranberry proanthocyanidins improve intestinal sIgA during elemental enteral nutrition</article-title><source>JPEN J Parenter Enteral Nutr</source><year>2014</year><volume>38</volume><fpage>107</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">23359014</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nantz</surname><given-names>MP</given-names></name><name><surname>Rowe</surname><given-names>CA</given-names></name><name><surname>Muller</surname><given-names>CE</given-names></name><name><surname>Creasy</surname><given-names>R</given-names></name><name><surname>Chapkin</surname><given-names>C</given-names></name><name><surname>Pasqualini</surname><given-names>S</given-names></name><etal/></person-group><article-title>Cranberry phytochemicals modify human immune function and appear to reduce the severity of cold and flu symptoms</article-title><source>FASEB J</source><year>2010</year><volume>24</volume><fpage>326</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">19741173</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nantz</surname><given-names>MP</given-names></name><name><surname>Rowe</surname><given-names>CA</given-names></name><name><surname>Muller</surname><given-names>C</given-names></name><name><surname>Creasy</surname><given-names>R</given-names></name><name><surname>Colee</surname><given-names>J</given-names></name><name><surname>Khoo</surname><given-names>C</given-names></name><etal/></person-group><article-title>Consumption of cranberry polyphenols enhanceshuman &#x003b3;&#x003b4;-T cell proliferation and reduces the number of symptoms associated with colds and influenza: A randomized, placebo-controlled intervention study</article-title><source>Nutr J</source><year>2013</year><volume>12</volume><fpage>161</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">24330619</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ofek</surname><given-names>I</given-names></name><name><surname>Goldhar</surname><given-names>J</given-names></name><name><surname>Sharon</surname><given-names>N</given-names></name></person-group><article-title>Anti-<italic>Escherichia coli</italic> adhesin activity of cranberry and blueberry juices</article-title><source>Adv Exp Med Biol</source><year>1996</year><volume>408</volume><fpage>179</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">8895790</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>AB</given-names></name><name><surname>Reed</surname><given-names>JD</given-names></name><name><surname>Krueger</surname><given-names>CG</given-names></name><name><surname>Winterbottom</surname><given-names>R</given-names></name><name><surname>Cunningham</surname><given-names>DG</given-names></name><name><surname>Leahy</surname><given-names>M</given-names></name></person-group><article-title>A-type cranberry proanthocyanidins and uropathogenicbacterial anti-adhesion activity</article-title><source>Phytochemistry</source><year>2005</year><volume>66</volume><fpage>2281</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">16055161</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>T</given-names></name><name><surname>Xiao</surname><given-names>SD</given-names></name></person-group><article-title>Cranberry juice cocktail for prevention and treatment of <italic>Helicobacter pylori</italic> infection in mice model</article-title><source>Chin J Gastroenterol</source><year>2003</year><volume>8</volume><fpage>265</fpage><lpage>8</lpage></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>K</given-names></name><name><surname>Go</surname><given-names>VL</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>You</surname><given-names>WC</given-names></name></person-group><article-title>Efficacy of cranberry juice on <italic>Helicobacter pylori</italic> infection: A double-blind, randomized placebo-controlled trial</article-title><source>Helicobacter</source><year>2005</year><volume>10</volume><fpage>139</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">15810945</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotteland</surname><given-names>M</given-names></name><name><surname>Brunser</surname><given-names>O</given-names></name><name><surname>Cruchet</surname><given-names>S</given-names></name></person-group><article-title>Systematic review: Are probiotics useful in controlling gastric colonization by <italic>Helicobacter pylori</italic>?</article-title><source>Aliment Pharmacol Ther</source><year>2006</year><volume>23</volume><fpage>1077</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">16611267</pub-id></element-citation></ref></ref-list></back></article>